GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hansoh Pharmaceutical Group Co Ltd (HKSE:03692) » Definitions » Inventories, Raw Materials & Components

Hansoh Pharmaceutical Group Co (HKSE:03692) Inventories, Raw Materials & Components : HK$151 Mil (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Hansoh Pharmaceutical Group Co Inventories, Raw Materials & Components?

Hansoh Pharmaceutical Group Co's inventories, raw materials & components for the quarter that ended in Dec. 2023 was HK$151 Mil.

Hansoh Pharmaceutical Group Co's quarterly raw materials declined from Dec. 2022 (HK$117 Mil) to Jun. 2023 (HK$0 Mil) but then increased from Jun. 2023 (HK$0 Mil) to Dec. 2023 (HK$151 Mil).

Hansoh Pharmaceutical Group Co's annual raw materials increased from Dec. 2021 (HK$117 Mil) to Dec. 2022 (HK$117 Mil) and increased from Dec. 2022 (HK$117 Mil) to Dec. 2023 (HK$151 Mil).


Hansoh Pharmaceutical Group Co Inventories, Raw Materials & Components Historical Data

The historical data trend for Hansoh Pharmaceutical Group Co's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hansoh Pharmaceutical Group Co Inventories, Raw Materials & Components Chart

Hansoh Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Raw Materials & Components
Get a 7-Day Free Trial 99.43 94.28 116.55 117.08 151.03

Hansoh Pharmaceutical Group Co Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 116.55 - 117.08 - 151.03

Hansoh Pharmaceutical Group Co Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Hansoh Pharmaceutical Group Co (HKSE:03692) Business Description

Traded in Other Exchanges
Address
287 Xiangke Road, Pudong New District, Shanghai, CHN, 201210
Hansoh Pharmaceutical Group Co Ltd is a research and development-driven pharmaceutical company in China. The company holds a broad, diversified drug portfolio in CNS diseases, oncology, anti-infectives, and diabetes. Further, it also focuses on metabolic diseases and anti-tumor. The majority of revenue is generated from the sale of pharmaceutical products in Mainland China.
Executives
Cen Junda 2307 Founder of a discretionary trust who can infl
Cantrust (far East) Limited 2301 Trustee
Jqc Holding Limited 2201 Interest of corporation controlled by you
Jqc International Limited 2201 Interest of corporation controlled by you
Sun Yuan 2101 Beneficial owner
Harmonia Holding Investing (ptc) Limited 2201 Interest of corporation controlled by you
Stellar Infinity Company Ltd. 2101 Beneficial owner
Sunrise Investment Advisors Limited 2201 Interest of corporation controlled by you
Zhong Huijuan 2307 Founder of a discretionary trust who can infl
Apex Medical Company Ltd. 2101 Beneficial owner

Hansoh Pharmaceutical Group Co (HKSE:03692) Headlines

No Headlines